The U.S. Food and Drug Administration (FDA) has approved the first triptan medication to treat migraines in adolescents. The drug, called Almotriptan, was already approved to treat migraines in adults, but now may be used by teens. The drug's maker, Almirall, has been granted a patent extension on the medication until 2015.
Read moreEarlier, I posted about some insurance companies denying payment for medications prescribed for Migraine prevention, saying it was because... Read more »
With Migraine, as with many other diseases and conditions, there are fewer medications that have been approved by the FDA for children than... Read more »
St. Jude Medical, Inc., recently became the only manufacturer to receive the primary European regulatory acceptance, the European CE Mark... Read more »
In April, I reported on a new Migraine abortive medication, Trexima. Trexima combines sumatriptan (Imitrex) and naproxen sodium. Two... Read more »
The FDA has approved a new prescription medication for the acute treatment of Migraine attacks, Cambia, developed by Kowa Pharmaceuticals... Read more »
The U.S. Food and Drug Administration (FDA) has approved the first triptan medication to treat migraines in adolescents. The drug, called... Read more »
Migraine prevention is one of the most important issues facing Migraineurs who experience frequent and / or debilitating Migraine attacks. The vast... Read more »
There's good news about abortive treatment of Migraine with aura - without medications. A portable Transcranial Magnetic Stimulation (TMS) device... Read more »
The FDA has now approved Botox (onabotulinumtoxinA) for the treatment of chronic Migraine. Russell Katz, M.D., director of the Division of... Read more »
"We have really great Migraine-specific medications available, and they're not being prescribed to people who could benefit from them… Often,... Read more »